LINC01798: A Potential Drug Target and Biomarker (G100507073)

Target Name: LINC01798

NCBI ID: G100507073

LINC01798

Other Name(s): long intergenic non-protein coding RNA 1798 | Long intergenic non-protein coding RNA 1798

LINC01798: A Potential Drug Target and Biomarker

LINC01798 is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is a key regulator of cell growth and differentiation, and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a potential drug target, LINC01798 has the potential to treat a wide range of conditions.

The LINC01798 protein is composed of 156 amino acids and has a calculated molecular weight of 19.9 kDa. It is expressed in a variety of tissues, including the brain, heart, and kidneys, and is highly expressed in the human placenta. It is also a potent inhibitor of the protein kinase PDK4, which is a key regulator of cell growth and differentiation.

In addition to its role as a drug target, LINC01798 has also been identified as a potential biomarker for a number of diseases. For example, it has been shown to be highly expressed in the brains of individuals with Alzheimer's disease, and has been used as a biomarker to predict the severity of this disease. It has also been shown to be expressed in the blood vessels of individuals with heart disease, and has been used as a biomarker for this condition.

In addition to its potential as a drug target and biomarker, LINC01798 is also of interest as a potential therapeutic target for a number of other diseases. For example, it has been shown to be involved in the regulation of cell adhesion, which is important for the development and maintenance of tissues and organs. It has also been shown to be involved in the regulation of cell migration, which is important for the development and maintenance of tissues and organs.

In conclusion, LINC01798 is a protein that has the potential to be a drug target and biomarker for a wide range of diseases. Its role as a regulator of cell growth and differentiation, as well as its potential as a therapeutic target for a number of conditions, make it an attractive target for further research and development. Further studies are needed to fully understand the biology and potential therapeutic applications of LINC01798.

Protein Name: Long Intergenic Non-protein Coding RNA 1798

The "LINC01798 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01798 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets